Sechenov School
Home › Biochemistry › RNA Processing

RNA Processing

For medical students2 min readUpdated 2026-10-10

RNA processing is a series of post-transcriptional modifications that convert a primary transcript into a functionally active "mature" molecule. This multi-step process includes protecting the ends of the RNA from degradation and the precise excision of non-coding genetic insertions, which is essential for subsequent cellular protein biosynthesis.

Start of modifications5' capping begins when the primary transcript reaches a length of ~30 nucleotides
Specific bondGTP is attached to the 5' end of the pre-mRNA via an unusual 5',5'-phosphodiester bond
Types of mature rRNAsThe 28S, 18S, and 5.8S forms are generated from a single high-molecular-weight precursor
Important exceptiontRNAs and rRNAs lack a cap and a poly-A tail at their ends

Protection and Modification of Pre-mRNA Ends

The formation of a mature molecule begins with 5' capping. This mechanism is triggered very early—when the synthesized primary transcript is only about 30 nucleotides long.

The core of the process involves attaching a guanosine triphosphate (GTP) residue to the pre-mRNA fragment. Notably, the GTP molecule attaches via its 5' carbon to the 5' end of the transcript, forming an atypical 5',5'-phosphodiester bond. The final step of capping is the methylation of the guanine within the GTP. The resulting "cap" structure has the form 7-methyl-G(5')ppp(5')X..., where X denotes the first nucleotide of the pre-mRNA chain.

The second major modification is 3' polyadenylation, which occurs after transcription is complete. The enzyme poly-A polymerase carries out this step, catalyzing the synthesis of a poly-A tail at the 3' end of the primary transcript by building a chain of 100–200 adenylic acid residues. The poly-A tail performs two critical functions:

It must be emphasized that these protective elements are not present in all nucleic acids: transfer and ribosomal RNAs completely lack a cap and a poly-A sequence.

Internal Transcript Structure and Splicing

The primary transcript (pre-mRNA) is an exact complementary copy of the gene. It consists of two alternating types of sequences:

The process of excising introns from the primary transcript and joining the exon ends together to form a "mature" mRNA is called splicing.

Small nuclear ribonucleoproteins (snRNPs) are key players in the splicing mechanism. Each snRNP consists of a small nuclear RNA (snRNA) molecule and a protein core composed of several protomers. Together, these complexes form a large functional structure known as the spliceosome.

Steps of the splicing reaction:

  1. Individual snRNPs accurately recognize specific sequences within introns using base-pairing complementarity.
  2. The spliceosome catalyzes the cleavage of the 3',5'-phosphodiester bond precisely at the exon-intron junction.
  3. The ends of the two adjacent exons are then neatly ligated.

Post-Transcriptional Modifications of rRNA and Ribosome Assembly

Processing also affects ribosomal RNAs. rRNA maturation involves generating final "mature" molecules from a single common high-molecular-weight precursor. This processing yields mature rRNA types designated as 28S, 18S, and 5.8S.

All of these mature molecules become part of the ribosome — a vital cellular organelle that carries out protein biosynthesis.

In addition to ribosomal RNAs, the ribosome contains various proteins. These organelle components work together, and the functions of rRNAs and proteins within the ribosome fall into three categories:

Mnemonic

To remember pre-mRNA structure: Exons Exit to the cytoplasm (they are expressed/kept in mRNA). Introns In the nucleus stay behind (they are spliced out and degraded).

Frequently asked questions

What is the mechanism of alternative splicing?

Alternative splicing involves joining different combinations of exons from a primary transcript. It is often coupled with alternative polyadenylation. As a result, a single primary transcript can yield multiple different mature mRNAs, allowing a single gene to encode various protein isoforms.

Mechanisms include:

  • Alternative promoter usage — generating transcripts with different 5' ends and varying exon sets.
  • Alternative splice site selection — shifting the boundaries of exon inclusion.
  • Cassette exon inclusion/exclusion — adding or dropping specific exons.
How is transfer RNA (tRNA) processed?

tRNA processing involves a sequence of structural and chemical modifications of primary transcripts.

The process includes:

  • End trimming — shortening the molecule by removing extra sequences at the 5' and 3' ends.
  • Splicing — excising an intron located in the central region of the molecule (the anticodon loop).
  • Base modification — chemical alteration of 10–15% of nitrogenous bases (e.g., formation of dihydrouridine, ribothymidine, pseudouridine).
  • Acceptor stem completion — addition of the -CCA triplet to the 3' end, which is required for amino acid attachment.
At what point does capping begin?

5' capping starts very early, when the synthesized primary transcript reaches approximately 30 nucleotides in length.

What functions does the poly-A tail perform?

The poly-A tail, consisting of 100–200 adenylic acid residues, facilitates messenger RNA export from the nucleus and effectively slows down its cytoplasmic hydrolysis.

What is the spliceosome made of?

The spliceosome is assembled from small nuclear ribonucleoproteins (snRNPs). Each snRNP consists of a small nuclear RNA (snRNA) and a protein core containing multiple protomers.

Do ribosomal and transfer RNAs contain a cap and a poly-A tail?

No. A 5' cap and a 3' poly-A tail are characteristic of mRNA, whereas tRNA and rRNA lack these structures.

Go deeper

More topics in Biochemistry

Neonatal JaundiceProteoglycansChemical CarcinogenesisElectron Transport Chain InhibitorsPyridoxal PhosphateHemoglobinInositol Phosphate SystemCarbohydrate Digestion DisordersKetone Bodies: Synthesis, Oxidation and Clinical SignificanceAmmonia Metabolism: Sources, Transport, and DetoxificationIodothyroninesLesch-Nyhan Syndrome: Pathogenesis and Clinical FeaturesBiochemistry →